Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · May 26, 2017

Long-Term Outcomes Improve When Patients Are Switched to Clopidogrel After ACS

European Heart Journal

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Heart Journal
Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome: The TOPIC (Timing of Platelet Inhibition After Acute Coronary Syndrome) Randomized Study
Eur Heart J 2017 May 16;[EPub Ahead of Print], T Cuisset, P Deharo, J Quilici, TW Johnson, S Deffarges, C Bassez, G Bonnet, L Fourcade, JP Mouret, M Lambert, V Verdier, PE Morange, MC Alessi, JL Bonnet

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading